Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Gross Profit (2020 - 2025)

Historic Gross Profit for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$1.0 million.

  • iSpecimen's Gross Profit fell 19336.81% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213769.0, marking a year-over-year decrease of 10428.83%. This contributed to the annual value of $4.0 million for FY2024, which is 2191.72% down from last year.
  • As of Q3 2025, iSpecimen's Gross Profit stood at -$1.0 million, which was down 19336.81% from $268958.0 recorded in Q2 2025.
  • iSpecimen's Gross Profit's 5-year high stood at $1.8 million during Q3 2021, with a 5-year trough of -$1.0 million in Q3 2025.
  • For the 5-year period, iSpecimen's Gross Profit averaged around $1.1 million, with its median value being $1.3 million (2022).
  • As far as peak fluctuations go, iSpecimen's Gross Profit soared by 12232.08% in 2024, and later plummeted by 19336.81% in 2025.
  • Over the past 5 years, iSpecimen's Gross Profit (Quarter) stood at $1.3 million in 2021, then rose by 16.98% to $1.6 million in 2022, then dropped by 26.04% to $1.1 million in 2023, then crashed by 86.81% to $151352.0 in 2024, then tumbled by 783.38% to -$1.0 million in 2025.
  • Its Gross Profit stands at -$1.0 million for Q3 2025, versus $268958.0 for Q2 2025 and $400231.0 for Q1 2025.